Taro Pharmaceuticals class action alleges company responsible for data breach

Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.

Taro Pharmaceuticals data breach class action lawsuit: 

• Who: A Taro Pharmaceuticals employee sued the company.
• Why: The plaintiff claims the company’s negligence led to a data breach. 
• Where: The Taro Pharmaceuticals data breach class action was filed in a New York federal court. 
• What are my options: Norton LifeLock provides data security options.

Taro Pharmaceuticals was negligent with its employees’ data, leading to their private information being leaked in a cyberattack, a new class action lawsuit alleges.

Plaintiff Jae Lee filed a class action lawsuit against Taro Pharmaceuticals USA Inc. May 8 in a New York federal court, alleging negligence.

Taro is an international pharmaceutical company that claims to develop high-quality, proprietary and off-patent pharmaceuticals for the United States, Canada, Israel and other countries around the world, the lawsuit states.

it stores “a litany” of highly sensitive personal identifiable information (PII) about its current and former employees that it failed to protect, according to the Taro Pharmaceuticals class action.

“Defendant lost control over that data when cybercriminals infiltrated its insufficiently protected computer systems in a data breach,” the lawsuit states. “Defendant had no effective means to prevent, detect, stop or mitigate breaches of its systems—thereby allowing cybercriminals unrestricted access to employee PII.”

Taro Pharmaceuticals failed to maintain reasonable security safeguards, data breach class action alleges

Lee says he is a data breach victim, receiving a data breach notice on or about April 20, 2023. 

According to the Taro Pharmaceuticals class action, cybercriminals breached Taro’s systems because it failed to adequately train its employees on cybersecurity and failed to maintain reasonable security safeguards or protocols to protect their PII. 

“In short, Defendant’s failures placed the Class’s PII in a vulnerable position—rendering them easy targets for cybercriminals,” the lawsuit alleges.

Lee sued on behalf of anyone whose data was compromised in the breach. He claims negligence, breach of contract and unjust enrichment and seeks certification of the class action, damages, fees, costs and a jury trial. 

In related Taro news, a Pennsylvania federal judge recently signed off on a settlement to end price-fixing claims from direct purchasers against Sun Pharmaceutical Industries Inc. and Taro Pharmaceutical Industries USA Inc.

What do you think of the allegations against Taro Pharmaceuticals in this case? Let us know in the comments! 

The plaintiff is represented by James J. Bilsborrow of Weitz & Luxenberg P.C. and Raina Borrelli and Samuel J. Strauss of Turkey & Strauss LLP.

The Taro Pharmaceuticals class action lawsuit is Jae Lee, et al. v. Taro Pharmaceuticals USA Inc., Case No. 7:23-cv-03834, in the U.S. District Court for the Southern District of New York. 

Read About More Class Action Lawsuits & Class Action Settlements:

• TMX Finance hit with another class action following data breach
• Class action lawsuit over LendingTree data breach headed to mediation
• American Bar Association class action claims data breach affected 1.3M members
• Dish Network class action alleges data breach compromised customer, employee info